A detailed history of Oppenheimer Asset Management Inc. transactions in Viatris Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 71,129 shares of VTRS stock, worth $741,875. This represents 0.01% of its overall portfolio holdings.

Number of Shares
71,129
Previous 60,144 18.26%
Holding current value
$741,875
Previous $651,000 30.41%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$11.27 - $13.53 $123,800 - $148,627
10,985 Added 18.26%
71,129 $849,000
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $32,133 - $39,754
-3,664 Reduced 5.74%
60,144 $651,000
Q3 2023

Nov 07, 2023

SELL
$9.59 - $11.35 $105 - $124
-11 Reduced 0.02%
63,808 $629,000
Q2 2023

Aug 02, 2023

BUY
$9.02 - $10.29 $177,748 - $202,774
19,706 Added 44.67%
63,819 $636,000
Q1 2023

May 10, 2023

SELL
$9.2 - $12.26 $10,396 - $13,853
-1,130 Reduced 2.5%
44,113 $424,000
Q4 2022

Feb 06, 2023

SELL
$8.72 - $11.56 $88,473 - $117,287
-10,146 Reduced 18.32%
45,243 $503,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $9,590 - $12,588
1,131 Added 2.08%
55,389 $472,000
Q2 2022

Aug 08, 2022

SELL
$9.95 - $12.27 $6,298 - $7,766
-633 Reduced 1.15%
54,258 $568,000
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $246,535 - $387,017
25,131 Added 84.45%
54,891 $597,000
Q4 2021

Feb 02, 2022

SELL
$12.09 - $14.68 $67,063 - $81,429
-5,547 Reduced 15.71%
29,760 $403,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $4,173 - $4,765
-315 Reduced 0.88%
35,307 $479,000
Q2 2021

Aug 03, 2021

BUY
$12.97 - $16.15 $25,940 - $32,299
2,000 Added 5.95%
35,622 $510,000
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $456,922 - $623,351
33,622 New
33,622 $470,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.